Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 • 2,715 citations

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

2001 • 1,521 citations

Competing interests: none declared.

2006 • 1,414 citations

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

2003 • 750 citations

The endothelin system in pulmonary arterial hypertension

2004 • 498 citations

Hemodynamics and Survival in Patients With Pulmonary Arterial Hypertension Related to Systemic Sclerosis*

2003 • 431 citations

Primary Pulmonary Hypertension

2000 • 361 citations

Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients

1996 • 319 citations

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era

2005 • 242 citations

Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival

2001 • 236 citations

Primary and secondary pulmonary hypertension in systemic lupus erythematosus

2000 • 126 citations

Pulmonary hypertension in systemic lupus erythematosus

1999 • 113 citations

Pulmonary hypertension associated with connective tissue disease

2002 • 102 citations

A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism

2004 • 74 citations

Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence

2005 • 15 citations